| 2025 |
Designing an Intelligent Cyber-Biological System for Enhanced Analysis and Monitoring of Organoids |
Contributo in atti di convegno pubblicato in volume |
Vai |
| 2025 |
Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patients |
Articolo in rivista |
Vai |
| 2025 |
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction |
Review essay (rassegna critica) |
Vai |
| 2025 |
A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening |
Articolo in rivista |
Vai |
| 2024 |
Lipid droplets and small extracellular vesicles: More than two independent entities |
Articolo in rivista |
Vai |
| 2024 |
The miRNA Contribution in Adipocyte Maturation |
Articolo in rivista |
Vai |
| 2024 |
Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells |
Articolo in rivista |
Vai |
| 2023 |
Recapitulating thyroid cancer histotypes through engineering embryonic stem cells |
Articolo in rivista |
Vai |
| 2023 |
Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer |
Articolo in rivista |
Vai |
| 2023 |
EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas |
Articolo in rivista |
Vai |
| 2023 |
Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment |
Articolo in rivista |
Vai |
| 2022 |
Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2022 |
Targeting epigenetic alterations in cancer stem cells |
Review essay (rassegna critica) |
Vai |
| 2022 |
Cancer cell targeting by CAR-T cells: A matter of stemness |
Review essay (rassegna critica) |
Vai |
| 2022 |
Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy |
Review essay (rassegna critica) |
Vai |
| 2022 |
Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy |
Review essay (rassegna critica) |
Vai |
| 2022 |
Autologous adipose-derived stromal vascular fraction and platelet concentrates for the treatment of complex perianal fistulas |
Articolo in rivista |
Vai |
| 2021 |
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells |
Articolo in rivista |
Vai |
| 2021 |
Messing Up the Cancer Stem Cell Chemoresistance Mechanisms Supported by Tumor Microenvironment |
Review essay (rassegna critica) |
Vai |
| 2021 |
AKT3 expression in mesenchymal colorectal cancer cells drives growth and is associated with epithelial-mesenchymal transition |
Articolo in rivista |
Vai |
| 2021 |
FACS-based protocol to assess cytotoxicity and clonogenic potential of colorectal cancer stem cells using a Wnt/β-catenin signaling pathway reporter |
Articolo in rivista |
Vai |
| 2021 |
Adipose stem cell niche reprograms the colorectal cancer stem cell metastatic machinery |
Articolo in rivista |
Vai |
| 2021 |
Cancer stem cell biomarkers predictive of radiotherapy response in rectal cancer: A systematic review |
Review essay (rassegna critica) |
Vai |
| 2021 |
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy |
Articolo in rivista |
Vai |
| 2021 |
Targeting Phosphatases and Kinases: How to Checkmate Cancer |
Articolo in rivista |
Vai |
| 2021 |
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs |
Articolo in rivista |
Vai |
| 2021 |
Adipose stromal cells promote the transition of colorectal cancer cells toward a mesenchymal-like phenotype |
Nota o commento |
Vai |
| 2020 |
ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2020 |
The Hippo Show Must Go On: YAP Activation as a Therapeutic Strategy in Colorectal Cancer |
Articolo in rivista |
Vai |
| 2020 |
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities |
Review essay (rassegna critica) |
Vai |
| 2020 |
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant |
Articolo in rivista |
Vai |
| 2019 |
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells |
Articolo in rivista |
Vai |
| 2019 |
Cancer Stem Cells: From Birth to Death |
Capitolo o Saggio |
Vai |
| 2019 |
Meeting the Challenge of Targeting Cancer Stem Cells |
Articolo in rivista |
Vai |
| 2018 |
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models |
Articolo in rivista |
Vai |
| 2018 |
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells |
Articolo in rivista |
Vai |
| 2017 |
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage |
Articolo in rivista |
Vai |
| 2017 |
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer |
Articolo in rivista |
Vai |
| 2017 |
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma |
Articolo in rivista |
Vai |
| 2017 |
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients |
Articolo in rivista |
Vai |
| 2017 |
Innovative Therapeutic Strategies Targeting Colorectal Cancer Stem Cells |
Recensione in rivista |
Vai |
| 2017 |
Role of Type I and II interferons in colorectal cancer and melanoma |
Recensione in rivista |
Vai |
| 2017 |
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer |
Articolo in rivista |
Vai |
| 2017 |
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition |
Articolo in rivista |
Vai |
| 2016 |
Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform. |
Articolo in rivista |
Vai |
| 2016 |
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis |
Articolo in rivista |
Vai |
| 2016 |
Epithelial-mesenchymal transition: A new target in anticancer drug discovery |
Articolo in rivista |
Vai |
| 2016 |
Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers |
Articolo in rivista |
Vai |
| 2016 |
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype |
Articolo in rivista |
Vai |
| 2015 |
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging |
Articolo in rivista |
Vai |
| 2015 |
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells |
Articolo in rivista |
Vai |
| 2015 |
A versatile ultrasound system for in vitro experiments |
Proceedings |
Vai |
| 2015 |
Normal vs cancer thyroid stem cells: the road to transformation |
Recensione in rivista |
Vai |
| 2015 |
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. |
Articolo in rivista |
Vai |
| 2015 |
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer |
Articolo in rivista |
Vai |
| 2015 |
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology |
Articolo in rivista |
Vai |
| 2015 |
Targeting cancer stem cells and the tumor microenvironment |
Capitolo o Saggio |
Vai |
| 2015 |
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance |
Articolo in rivista |
Vai |
| 2015 |
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy |
Articolo in rivista |
Vai |
| 2014 |
Colorectal Cancer Stem Cells: From the Crypt to the Clinic |
Articolo in rivista |
Vai |
| 2014 |
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer |
Articolo in rivista |
Vai |
| 2014 |
Estrogens and stem cells in thyroid cancer |
Articolo in rivista |
Vai |
| 2014 |
γδ T cells as a potential tool in colon cancer immunotherapy |
Articolo in rivista |
Vai |
| 2014 |
Colorectal cancer defeating? Challenge accepted! |
Recensione in rivista |
Vai |
| 2014 |
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment |
Articolo in rivista |
Vai |
| 2014 |
Role of exosomes released by colon cancer stem cells in the modulation of tumor microenvironment. |
Proceedings |
Vai |
| 2013 |
Tumor and its microenvironment: a synergistic interplay. |
Recensione in rivista |
Vai |
| 2013 |
Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes |
Articolo in rivista |
Vai |
| 2013 |
Chemotherapy Sensitizes Colon Cancer Initiating Cells to Vc9Vd2 T Cell-Mediated Cytotoxicity |
Articolo in rivista |
Vai |
| 2013 |
Cancer-Initiating Cells from Colorectal cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 |
Articolo in rivista |
Vai |
| 2013 |
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. |
Articolo in rivista |
Vai |
| 2013 |
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. |
Articolo in rivista |
Vai |
| 2012 |
Cancer stem cell definitions and terminology: the devil is in the details |
Articolo in rivista |
Vai |
| 2012 |
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas |
Articolo in rivista |
Vai |
| 2012 |
IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. |
Articolo in rivista |
Vai |
| 2012 |
CD133 as a target for colon cancer. |
Articolo in rivista |
Vai |
| 2011 |
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. |
Articolo in rivista |
Vai |
| 2011 |
Immunotherapy targeting colon cancer stem cells |
Recensione in rivista |
Vai |
| 2011 |
DOWN REGULATION OF LYMPHOCYTES APOPTOSIS IN GIRLS WITH PRECOCIOUS PUBERTY |
Poster pubblicato in rivista |
Vai |
| 2011 |
Differentiation, phenotype, and function of
interleukin-17-producing human V{gamma}9V{delta}2 T cells |
Articolo in rivista |
Vai |
| 2010 |
In vivo manipulation of Vgamma9Vdelta2 T cells with
zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast
cancer patients. |
Articolo in rivista |
Vai |
| 2010 |
Colon cancer stem cells: promise of targeted therapy. |
Articolo in rivista |
Vai |
| 2010 |
Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy |
Articolo in rivista |
Vai |
| 2010 |
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. |
Articolo in rivista |
Vai |
| 2010 |
Tumour vascularization via endothelial differentiation of glioblastoma stem-like
cells |
Articolo in rivista |
Vai |
| 2010 |
Survivin is regulated by interleukin-4 in colon cancer stem cells |
Articolo in rivista |
Vai |
| 2010 |
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. |
Articolo in rivista |
Vai |
| 2010 |
V{gamma}9V{delta}2 T Lymphocytes Efficiently
Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and
Imatinib-Resistant Chronic Myelogenous Leukemia Cells. |
Articolo in rivista |
Vai |
| 2010 |
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer |
Articolo in rivista |
Vai |
| 2010 |
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. |
Articolo in rivista |
Vai |
| 2009 |
Role of interleukin-4 on colon cancer stem cell survival |
Proceedings |
Vai |
| 2009 |
Therapeutic implications of Cancer Initiating Cells. |
Articolo in rivista |
Vai |
| 2009 |
Survivina e induzione dell'apoptosi |
Tesi di dottorato pre 2013 |
Vai |
| 2009 |
Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy |
Articolo in rivista |
Vai |
| 2009 |
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. |
Articolo in rivista |
Vai |
| 2008 |
CD 95 and TRAIL induced lymphocytes apoptosis in girls with precocious puberty. |
Abstract in rivista |
Vai |
| 2008 |
Crucial role of interleukin-4 in the survival of colon cancer stem cells |
Articolo in rivista |
Vai |
| 2008 |
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme |
Articolo in rivista |
Vai |
| 2008 |
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. |
Articolo in rivista |
Vai |
| 2008 |
Isolation and culture of colon cancer stem cells. |
Articolo in rivista |
Vai |
| 2007 |
METHOD FOR THE PURIFICATION AND AMPLIFICATION OF TUMORAL STEM CELLS |
Brevetto |
Vai |
| 2007 |
ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREAMENT OF CANCER |
Brevetto |
Vai |
| 2007 |
Human fetal aorta contains vascular progenitor cells capable of inducing
vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of
peripheral ischemia. |
Articolo in rivista |
Vai |
| 2007 |
Role of Th cytokines in thyroid autoimmunity |
Articolo in rivista |
Vai |
| 2007 |
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells |
Articolo in rivista |
Vai |
| 2006 |
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells |
Articolo in rivista |
Vai |
| 2006 |
Autocrine production of IL-4 confers resistance to chemotherapy and CD-95 induced cell death in cancer cells. |
Proceedings |
Vai |
| 2006 |
Thyroid stem cells: phenotypic properties, differentiation, potential and regulation by bone morphogenetic proteins |
Proceedings |
Vai |
| 2006 |
Optimisation of cancer therapy by sensitization of cancer stem cells within tumors to death inducing regimens |
Proceedings |
Vai |
| 2006 |
Programmed cell death in desease |
Proceedings |
Vai |
| 2006 |
ROLE OF IL-4 AND IL-10 CYTOKYNES IN THE PATHOGENIC MECHANISM OF THYROID CANCER. |
Capitolo o Saggio |
Vai |
| 2006 |
Detection of apoptosis in tissue |
Proceedings |
Vai |
| 2006 |
INHIBITION OF TKTL1-TRANSKETOLASE OFFERS NEW THERAPEUTIC STRATEGIES FOR CANCER PATIENTS WITH INVASVE TUMOURS OR METASTASES |
Proceedings |
Vai |
| 2006 |
Involvement of MUC1 oncoprotein in thyroid cancer resistance to chemoterapeutic drugs |
Proceedings |
Vai |
| 2006 |
Optimisation of cancer therapy by sensitization of cancer stem cells within tumorsto death indicing regimens |
Proceedings |
Vai |
| 2006 |
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. |
Articolo in rivista |
Vai |
| 2006 |
CANCER STEM CELLS CONTRIBUTE TO THE AGGRESSIVE BEHAVIOUR OF HUMAN EPITHELIAL COLON CANCER. |
Proceedings |
Vai |
| 2006 |
Sensitizing cells for apoptosis by selectively blocking cytokines. |
Brevetto |
Vai |
| 2006 |
Annexin-1 Downregulation in Thyroid Cancer Correlates to the Degree of Tumor Differentiation. |
Articolo in rivista |
Vai |
| 2006 |
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. |
Articolo in rivista |
Vai |
| 2005 |
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells |
Articolo in rivista |
Vai |
| 2005 |
NF-kappaB protects Behcet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins |
Articolo in rivista |
Vai |
| 2005 |
IL-4 protects cancer stem cell from apoptosis |
Proceedings |
Vai |
| 2005 |
Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells |
Articolo in rivista |
Vai |
| 2005 |
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing igand–Mediated Destruction. |
Articolo in rivista |
Vai |
| 2005 |
Il-4 protects cancer cells from CD95 induced apoptosis |
Proceedings |
Vai |
| 2005 |
ROLE OF IL-4 AND IL-10 CYTOKYNES IN THE PATHOGENIC MECHANISM OF THYROID CANCER |
Capitolo o Saggio |
Vai |
| 2005 |
Minimal residual disease: study of cancer stem cells. |
Proceedings |
Vai |
| 2005 |
PED/PEA-15 mediates AKT dependent chemoresistance in human breast cancer cells |
Proceedings |
Vai |
| 2005 |
IL-4 protects cancers cells from CD95 induced apoptosis |
Proceedings |
Vai |
| 2004 |
Role of apoptosis in autoimmunity |
Articolo in rivista |
Vai |
| 2004 |
Characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells. |
Proceedings |
Vai |
| 2004 |
Il-4 and IL 10 up regulate FLIP and PED conferring CD95-induced apoptosis refractoriness |
Proceedings |
Vai |
| 2004 |
SENSITIZING CELLS FOR APOPTOSIS BY SELECTIVELY BLOCKING CYTOKINES |
Brevetto |
Vai |
| 2004 |
Metodo per la purificazione e l’ampliamento di cellule staminali tumorali |
Brevetto |
Vai |
| 2004 |
Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin |
Articolo in rivista |
Vai |
| 2004 |
METHOD FOR THE PURIFICATION AND AMPLIFICATION OF TUMORAL STEM CELLS |
Brevetto |
Vai |
| 2004 |
cFLIPL inhibits TRAIL-mediated NFkB activation and apoptosis induction in human kerationocytes. |
Proceedings |
Vai |
| 2004 |
Th2 cytokines induce chemotherapy resistance in epithelial tumors via PI3K/AKT pathway |
Proceedings |
Vai |
| 2004 |
Bisphosphonates sensitize osteosarcoma cells to chemoterapeutic drugs |
Proceedings |
Vai |
| 2004 |
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins |
Articolo in rivista |
Vai |
| 2004 |
cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes |
Articolo in rivista |
Vai |
| 2004 |
Interleukin 4 production in solid tumors increases cancer cell survival via upregulation of cFlip and Bclxl |
Proceedings |
Vai |
| 2004 |
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins |
Articolo in rivista |
Vai |
| 2004 |
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs |
Articolo in rivista |
Vai |
| 2003 |
Thyroid Cancer Resistance to Chemotherapeutic Drugs via Autocrine Production of
Interleukin-4 and Interleukin-10 |
Articolo in rivista |
Vai |
| 2003 |
Islet Beta-Cell Apoptosis Triggered in Vivo by Interleukin-1
Is Not Related to the Inducible Nitric Oxide Synthase
Pathway: Evidence for Mitochondrial Function
Impairment and Lipoperoxidation |
Articolo in rivista |
Vai |
| 2002 |
High Levels of Exogenous C2-Ceramide Promote Morphological and Biochemical Evidences of Necrotic Features in Thyroid Follicular Cells |
Articolo in rivista |
Vai |
| 2000 |
Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease |
Articolo in rivista |
Vai |
| 1999 |
Defective apoptosis as potential mechanism in the tumorogenesis of myelolipoma |
Articolo in rivista |
Vai |
